Skip to content

Thomas Zeffiro

5 papers in the library · 319 citations · publishing 2015-2026

Papers

Sort Most recent Most cited

Rapid antidepressant potential of nitrous oxide: current state and major questions.

Molecular Psychiatry June 1, 2026 Charles F Zorumski, Joseph Cichon, Yukitoshi Izumi et al. 5 citations

The success of ketamine, a dissociative anesthetic and non-competitive N-methyl-D-aspartate receptor (NMDAR) antagonist, as a rapidly acting antidepressant has ignited efforts to identify other novel depression treatments. In recent years, several clinical trials indicated that nitrous oxide (N2O), an inhalational dissociative anesthetic in clinical use for over 150 years, also has rapid and...

Nitrous Oxide Alters Functional Connectivity in Medial Limbic Structures in Treatment-Resistant Major Depression.

medRxiv : the preprint server for health sciences August 17, 2024 Charles R Conway, Ben Julian A Palanca, Thomas Zeffiro et al. preprint

While nitrous oxide (N2O) has demonstrated antidepressant properties in treatment-resistant major depression (TRD), little is known about neural mechanisms mediating these effects. Employing serial resting-state functional magnetic resonance imaging (rs-fMRI), we compared spatiotemporal effects of inhaled N2O on brain functional connectivity in TRD patients (n=14) and non-depressed healthy...

Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder

Schizophrenia Bulletin June 20, 2024 Mary F. Brunette, Robert M. Roth, Christi L. Trask et al. 5 citations

BACKGROUND AND HYPOTHESIS: Up to 43% of people with schizophrenia have a lifetime cannabis use disorder (CUD). Tetrahydrocannabinol (THC) has been shown to exacerbate psychosis in a dose-dependent manner, but little research has assessed its effects on schizophrenia and co-occurring CUD (SCZ-CUD). In this double-dummy, placebo-controlled trial (total n = 130), we hypothesized that a modest dose...

Persistent Brain Connectivity Changes in Healthy Volunteers Following Nitrous Oxide Inhalation.

Biological Psychiatry Global Open Science October 1, 2023 Ben Julian A Palanca, Charles R Conway, Thomas Zeffiro et al.

Nitrous oxide holds promise in the treatment of major depressive disorder. Its psychotropic effects and NMDA receptor antagonism have led to comparisons with ketamine. Despite longstanding use, persistent effects of nitrous oxide on the brain have not been characterized. Sixteen healthy volunteers were recruited in a double-blind crossover study. In randomized order, individuals underwent a...

Meditation leads to reduced default mode network activity beyond an active task

Cognitive Affective & Behavioral Neuroscience April 22, 2015 Kathleen A. Garrison, Thomas Zeffiro, Dustin Scheinost et al. 309 citations

Meditation has been associated with relatively reduced activity in the default mode network, a brain network implicated in self-related thinking and mind wandering. However, previous imaging studies have typically compared meditation to rest, despite other studies having reported differences in brain activation patterns between meditators and controls at rest. Moreover, rest is associated with...